5200 ILLUMINA WAY, SAN DIEGO, CA
Financial Results, Press Release
Completes Acquisition of SomaLogic
Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Appoints Dr. Eric Green as Chief Medical Officer
Illumina Completes $500 Million Public Offering of 4.750% Notes Due 2030
Illumina Enters Underwriting Agreement for $500 Million Notes Offering
Reports Financial Results for Third Quarter of Fiscal Year 2025
Reports Financial Results for Second Quarter of Fiscal Year 2025
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Free Writing Prospectus
Specialized Disclosure Report
Definitive Revised Proxy Statement